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Purpose or Objective: MLC and couch tracking are promising 
techniques for intrafractional tumor motion management. 
However, both techniques have their limitations that result 
in residual dosimetric errors: MLC tracking perpendicular to 
the MLC leaves is limited by the finite MLC leaf width, while 
couch tracking has slower dynamics than the MLC and might 
be uncomfortable for the patient. Here, we suggest a range 
of potential hybrid MLC-couch tracking strategies and test 
the performance of each strategy with extensive tracking 
simulations. 
 
Material and Methods: Three hybrid MLC-couch tracking 
strategies were investigated and compared with pure MLC 
tracking and pure couch tracking. Dividing the target motion 
into motion parallel and perpendicular to the MLC leaves in 
beam’s eye view, the investigated tracking strategies were as 
follows (in order or increasing MLC tracking fraction). 1) Pure 
couch tracking; 2) Couch for all perpendicular target motion 
and MLC for parallel motion; 3) Couch for perpendicular 
motion below one leaf width and MLC for the remaining 
motion; 4) Same as 3) except that the couch only adapts to 
stable perpendicular shifts with standard deviation below 
0.5mm during the last second; 5) Pure MLC tracking.  
The current developer release of TrueBeam tracking system 
does not allow for hybrid MLC-couch tracking, but our in-
house built tracking simulator allowed investigation of the 
hybrid strategies. The simulator was experimentally validated 
to mimic the TrueBeam MLC and couch tracking system. 
Tracking treatments with each tracking strategy were 
simulated for 160 lung tumor and 695 prostate trajectories. A 
high and a low modulated VMAT treatment (1 arc) with MLC 
motion in the superior-inferior direction were simulated for 
each trajectory. 
The tracking performance of each simulated treatment was 
quantified as the mean MLC exposure error in beam’s eye 
view. The MLC exposure error is the sum of under-exposed 
areas Au (MLC shielded areas that should ideally be exposed) 
and over-exposed areas Ao (MLC exposed areas that should 
ideally be shielded). Au+Aohas previously been shown to be a 
good surrogate for dosimetric errors in tracking treatments. 
 
Results: The figure shows the cumulative distribution of 
mean MLC exposure errors for all trajectories and for 
trajectories with large motion (>3mm for prostate, >5mm for 
lung).The table shows the median reduction in the exposure 
error relative to pure MLC tracking as well as the mean 3D 
couch speed for all tracking strategies. 
 
 
 
 
Conclusion: Hybrid MLC-couch tracking offers a continuum of 
trade-offs between tracking accuracy and couch motion. A 
modest degree of couch tracking (strategy 4) largely 
improved MLC tracking, especially for prostate motion 
exceeding 3mm. Couch tracking perpendicular to the MLC 
leaves and MLC tracking parallel to the leaves (strategy 2) 
gave the most accurate tracking and a large couch motion 
reduction compared to pure couch tracking. 
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Purpose or Objective: Malignant mediastinal lymph nodes 
(LNs) are often included in the planning target volume for 
lung cancer patients (pts), but LN motion is not well 
investigated and this may potentially undermine the 
locoregional control. LNs in the mediastinum are difficult to 
visualize in cone-beam CT (CBCT) scans. In this study, the 
position of implanted fiducial markers obtained from daily 
CBCT projections was used to map the 3D intrafraction and 
interfraction motion of LN targets throughout the treatment 
course for ten lung cancer pts. 
 
Material and Methods: Ten lung cancer pts with Visicoil 
fiducial markers implanted in LN targets by EBUS 
bronchoscope received intensity modulated radiotherapy (RT) 
treatment in 30-33 fractions. A total of 26 LN targets with 
Visicoils were analyzed. A pre-treatment setup CBCT scan 
with ~675 projections was used for daily online soft tissue 
match on the primary tumor (GTV-T). The Visicoil positions 
were segmented offline in each projection using a semi-
automatic template-based algorithm. From the segmented 
Visicoil positions the 3D Visicoil trajectories were estimated 
with 11Hz sample rate by a probability-based estimation 
method. By frequency analysis, the 3D trajectories were 
separated into a cardiac and a breathing component. The 
motion ranges of the Visicoils were extracted in the left-right 
(LR), cranial-caudal (CC) and anterior-posterior (AP) direction 
for the total motion, as well as the separated cardiac and 
breathing induced motions. Also, the daily mean setup error 
of the Visicoils after the GTV-T soft-tissue match was 
extracted and used to calculate motion margins required for 
interfraction baseline shifts of the LN targets (using the 
formula 2.5Σ+0.7σ)*. 
 
Results: The 2-98 percentile motion ranges, for the patient 
group were in mean (with standard deviation) 2.1mm 
(0.5mm)(LR), 7.3mm (2.6mm)(CC), 3.3 mm (1.3mm)(AP). The 
cardiac induced mean motion ranges were 1.3mm 
0.7mm)(LR), 1.3mm (0.6mm)(CC), 2.3mm (1.5mm)(AP). The 
figure shows the averaged waveform in the coronal plane of 
the cardiac and breathing motion components of each Visicoil 
at the first RT fraction. The waveforms were obtained by 
averaging over a number of breathing/cardiac cycles. 
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Breathing motion was largest in the CC direction and more 
prominent for more caudal LNs. Cardiac induced motion was 
often (77%) largest in the AP direction (not shown) and 
tended to be largest for more cranial LNs, occasionally (44 %) 
being the dominant motion component. The daily baseline 
shifts from all fractions resulted in interfraction motion 
margins of 4.9mm(LR), 4.7mm(CC), and 6.4mm(AP). 
 
 
 
Conclusion: The motion of Visicoils in projection images of 
daily CBCTs was used to map and analyze intrafraction and 
interfraction motion of mediastinal LNs. While the motion 
was governed by breathing induced motion, the most cranial 
LNs had substantial cardiac induced motion.  
* Van Herk et al. Errors and margins in radiotherapy. 2004 
 
Symposium: Head and neck: reduction of margins and side 
effects  
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In the head and neck region, there are a lot of organs at risk 
(OAR) to take into account when making a treatment plan. 
The radiation fields are often very large and can go up to the 
brain and down to the lungs. The OAR in this region are 
responsible for a lot of body functions, like walking, talking, 
swallowing and taste. Some of the OAR are parallel organs, so 
they will be able to compensate the loss of part of the organ 
and others are serial organs, which implies that the dose to 
the entire organ has to be below a threshold value in order to 
maintain the functionality. 
In recent years most hospitals have started delineating more 
OAR in the head and neck region, but for some, there is no 
concensus on the constraints that have to be applied. 
Recently, consensus guidelines for head and neck OAR 
delineation were defined by Brouwer et al (1) To make sure 
that in the future we will be able to define constraints for 
these OAR we need a lot of data. This can only be obtained if 
there is consensus among institutes on delineation and 
reporting in the same manner.  
In this presentation the different OAR will be discussed and a 
short summary of recently published guidelines will be 
provided.  
(1) CT-based delineation of organs at risk in the head and 
neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC 
CTG, NCRI, NRG Oncology and TROG consensus guidelines. 
Brouwer, C. et al. Radiother. Oncol. 2015; 117: 83–90. 
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Purpose: These guidelines have been developed to assist 
Radiation TherapisTs (RTTs) in positioning, immobilisation, 
position verification and treatment for head and neck cancer 
(HNC) patients presenting for radiation therapy.  
 
Methods and materials: A critical review of the literature 
was undertaken by the authors, searching relevant databases 
including PubMed, Embase and Google Scholar. Search terms 
used included combinations of and Boolean operations of 
‘head and neck cancer’, ‘radiation therapy’, ‘radiotherapy’, 
‘positioning’, ’immobilisation’, ‘verification’, ‘cone beam 
CT’, and ‘electronic portal imaging’. Studies in English, 
French, Portuguese, Italian and German were included. Based 
on the literature review, a survey was developed to ascertain 
the current positioning, immobilisation and position 
verification methods for head and neck radiation therapy 
across Europe. The survey consisted of 40 questions, divided 
into 5 sections. The sections contained both open and closed 
questions on: Demographics, Patient Positioning, 
Immobilisation devices, CT/Simulation Practice, Position 
Verification as well as elements of quality assurance (QA) in 
relation to positioning and immobilisation. Data analysis was 
performed using SPSS Statistics version 20.0 (IBM SPSS 
Statistics for Windows. Armonk, NY: IBM Corp.). Descriptive 
statistics were calculated and appropriate figures and tables 
constructed. Cross tabulations were performed where 
appropriate to maximise data analysis.  
 
Results: Results from the European-wide survey indicated 
that a wide variety of treatment practices and treatment 
verification protocols are in operation for head and neck 
cancer patients across Europe currently. These ranged from 
3DCRT to VMAT and from daily online CBCT imaging to offline 
correction protocols using kV EPIs or in some cases, MV portal 
imaging. In terms of immobilisation, the majority of 
respondents use thermoplastic masks in their immobilisation 
of head and neck patients, with some variance in how 
shoulder position is maintained. The full results from this 
survey are available in the complete guideline document, 
available on the ESTRO website. Guidelines were given for: 
Positioning prior to thermoplastic mask 
constructionConstruction of thermoplastic maskThe CT 
procedureTreatment Verification and deliveryMatch 
Structures for Image Verification. 
 
Conclusion: The preparation of this guideline document has 
demonstrated that although there have been substantial 
changes in the set up, positioning, immobilisation and 
verification of head and neck cancer patients over the last 
number of years across Europe, significant variations still 
exist. These variations can be attributed to differences in 
resource type and quality, institutional protocols as well as 
considerable differences in education level of radiation 
therapy professionals across Europe. RTTs must be aware of 
the potential dosimetric impact of poor positioning and 
immobilisation and/or position verification procedures as 
well as their influence on required margins for HNC radiation 
therapy. These guidelines have been developed to provide 
RTTs with guidance on positioning, immobilisation and 
position verification of HNC patients. The guidelines will also 
provide RTTs with the means to critically reflect on their own 
daily clinical practice with this patient group. 
